Candriam S.C.A. Bio Techne Corp Transaction History

Candriam S.C.A.

$16.9 Billion
Q4 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$71.62 - $86.62 $83,795 - $101,345	1,170 Added 8.34%	15,192 $1.13 Million
Q4 2022 Feb 13, 2023	BUY	$80.67 - $352.29 $792,260 - $3.46 Million	9,821 Added 233.78%	14,022 $1.16 Million
Q3 2022 Nov 10, 2022	BUY	$282.54 - $391.85 $673,292 - $933,778	2,383 Added 131.08%	4,201 $1.19 Million
Q2 2022 Aug 03, 2022	SELL	$322.67 - $449.65 $5.04 Million - $7.02 Million	-15,618 Reduced 89.57%	1,818 $630,000
Q1 2022 May 13, 2022	SELL	$353.85 - $487.79 $18.1 Million - $24.9 Million	-51,025 Reduced 74.53%	17,436 $7.99 Million
Q4 2021 Feb 10, 2022	BUY	$456.15 - $525.06 $6.43 Million - $7.4 Million	14,095 Added 25.93%	68,461 $35.4 Million
Q3 2021 Nov 09, 2021	SELL	$444.87 - $538.88 $3.09 Million - $3.74 Million	-6,947 Reduced 11.33%	54,366 $26.3 Million
Q2 2021 Jul 20, 2021	SELL	$387.35 - $450.26 $18.2 Million - $21.1 Million	-46,970 Reduced 43.38%	61,313 $27.6 Million
Q1 2021 Apr 29, 2021	SELL	$314.62 - $411.0 $1,258 - $1,644	-4 Reduced -0.0%	108,283 $33 Million
Q4 2020 Jan 22, 2021	SELL	$246.9 - $321.87 $450,098 - $586,769	-1,823 Reduced 1.66%	108,287 $34.4 Million
Q3 2020 Oct 19, 2020	SELL	$232.22 - $282.96 $275,180 - $335,307	-1,185 Reduced 1.06%	110,110 $27.3 Million
Q2 2020 Jul 23, 2020	SELL	$185.43 - $279.56 $10.9 Million - $16.5 Million	-59,026 Reduced 34.66%	111,295 $29.4 Million
Q1 2020 May 26, 2020	BUY	$161.17 - $221.51 $2,256 - $3,101	14 Added 0.01%	170,321 $36.5 Million
Q4 2019 Jan 21, 2020	BUY	$189.68 - $222.09 $7.67 Million - $8.98 Million	40,450 Added 31.15%	170,307 $37,000
Q3 2019 Oct 21, 2019	BUY	$183.56 - $216.72 $4.01 Million - $4.73 Million	21,840 Added 20.22%	129,857 $25,000
Q2 2019 Aug 01, 2019	SELL	$188.72 - $215.43 $75,488 - $86,172	-400 Reduced 0.37%	108,017 $22.4 Million
Q1 2019 May 02, 2019	BUY	$136.09 - $200.44 $3.26 Million - $4.8 Million	23,928 Added 28.32%	108,417 $21.5 Million
Q4 2018 Feb 14, 2019	BUY	$132.75 - $203.8 $502,989 - $772,198	3,789 Added 4.7%	84,489 $12.2 Million
Q3 2018 Nov 07, 2018	BUY	$147.44 - $204.11 $4.44 Million - $6.14 Million	30,100 Added 59.49%	80,700 $16.5 Million
Q2 2018 Aug 14, 2018	BUY	$144.9 - $165.58 $956,340 - $1.09 Million	6,600 Added 15.0%	50,600 $7.49 Million
Q4 2017 Feb 07, 2018	SELL	$121.17 - $134.75 $3.21 Million - $3.57 Million	-26,500 Reduced 37.59%	44,000 $5.7 Million
Q3 2017 Nov 03, 2017	BUY	$113.59 - $123.78 $8.01 Million - $8.73 Million	70,500	70,500 $8.52 Million

Others Institutions Holding TECH

# of Institutions

616

Shares Held

156M

Call Options Held

200K

Put Options Held

15.3K

View Full List

About BIO-TECHNE Corp

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.59B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

More about TECH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

News

Stay updated on Candriam S.C.A. with notifications on news.

Account